Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates

Journal of Perinatology

Volumn 26, Issue 8, 2006, Pages 486-492

  Paquette, L ^a   Friedlich, P ^a   Ramanathan, R ^a   Seri, I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bowel perforation; Dexamethasone; Indomethacin; Spontaneous intestinal perforation; Very low birth weight neonate

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CONTRAST MEDIUM; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; ENEMA; ERYTHROMYCIN; GLYCEROL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE FACTOR; INDOMETACIN; INOTROPIC AGENT; METOCLOPRAMIDE;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; HYPOTENSION; INFANT; INTESTINE PERFORATION; LOW DRUG DOSE; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; PATENT DUCTUS ARTERIOSUS; POSTNATAL CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNIVARIATE ANALYSIS; VERY LOW BIRTH WEIGHT;

CASE-CONTROL STUDIES; DEXAMETHASONE; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; HYPOTENSION; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTESTINAL PERFORATION; MALE; RISK FACTORS;

EID: 33746478097     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211548     Document Type: Article

References (32)

1. Pumberger W, Mayr M, Kohlhauser C, Weninger M. Spontaneous localized intestinal perforation in very-low-birth-weight infants: A distinct clinical entity different from necrotizing enterocolitis. J Am Coll Surg 2002; 195: 796-803.
2. Holland AJ, Shun A, Martin HC, Cooke-Yarborough C, Holland J. Small bowel perforation in the premature neonate: Congenital or acquired? Pediatr Surg Intl 2003; 19: 489-494.
3. Attridge JT, Herman AC, Gurka MJ, Griffin MP, McGahren ED, Gordon PV. Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations. J Perinatol 2006; 26: 49-54.
4. Mintz AC, Applebaum H. Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg 1993; 28: 857-860.
5. Novack CM, Waffarn F, Sills JH, Pousti TJ, Warden MJ, Cunningham MD. Focal intestinal perforation in the extremely-low-birth-weight infant. J Perinatol 1994; 14: 450-453.
6. Komuro H, Urita Y, Hori T, Hirai M, Kudou S, Gotoh C et al. Perforation of the colon in neonates. J Pediatr Surg 2005; 40: 1916-1919.
7. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988; 113: 364-367.
8. Shorter NA, Liu JY, Mooney DP, Harmon BJ. Indomethacin-associated bowel perforations: A study of possible factors. J Pediatr Surg 1999; 34: 442-444.
9. DeLaet MH, Dassonville M, Johansson A, Lerminiaux C, Seghers V, Vanden Eijnden S et al. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone. Eur J Pediatr Surg 2000; 10: 323-327.
10. Cass DL, Brandt ML, Patel DL, Nuchtern JG, Minifee PK, Wesson DE. Peritoneal drainage as definitive treatment for neonates with isolated intestinal perforation. J Pediatr Surg 2000; 35: 1531-1536.
11. Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M. A comparison of the clinical presentation and outcome of focal intestinal perforation and necrotizing enterocolitis in very-low-birth-weight neonates. Pediatr Surg Int 2002; 18: 704-706.
12. Zamir O, Goldberg M, Udassin R, Peleg O, Nissan S, Eyal F. Idiopathic gastrointestinal perforation in the neonate. J Pediatr Surg 1988; 23: 335-337.
13. Meyer CL, Payne NR, Roback SA. Spontaneous isolated intestinal perforations in neonates with birth weight <1000 g not associated with necrotizing enterocolitis. J Pediatr Surg 1991; 26: 714-717.
14. Resch B, Mayr J, Kuttnig-Haim M, Reitere F, Ritschl E, Muller W. Spontaneous gastrointestinal perforation in very-low-birth-weight infants - a rare complication in a neonatal intensive care unit. Pediatr Surg Int 1998; 13: 165-167.
15. Raghuveer G, Speidel B, Marlow N, Porter H. Focal intestinal perforation in preterm infants is an emerging disease. Acta Paediatr 1996; 85: 237-239.
16. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2005 [E-Pub Dec, 1-7].
17. Adderson EE, Pappin A, Pavia AT. Spontaneous intestinal perforation in premature infants: A distinct clinical entity associated with systemic candidiasis. J Pediatr Surg 1998; 33: 1463-1467.
18. Ng PC, Fok TF, So KW, Wong W, Yip PKF, Liu K. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia. Pediatr Surg Int 1997; 12: 211-212.
19. Gordon P, Rutledge J, Sawin R, Thomas S, Woodrum D. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol 1999; 19: 573-577.
20. Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial. Pediatrics 1999; 104: 91-99.
21. Gordon PV, Marshall DD, Stiles AD, Price WA. The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: From the baby's bowel to the researcher's bench. Mol Genet Metab 2001; 72: 91-103.
22. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344: 95-101.
23. Gordon PV, Young ML, Marshall DD. Focal small bowel perforation: An adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 2001; 21: 156-160.
24. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 h) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1: CD001146.
25. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: A multicenter trial. Pediatrics 2004; 114: 1649-1657.
26. Schmidt B, David P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966-1972.
27. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; 1: CD003951.
28. Alpan G, Eyal F, Vinograd I, Udassin R, Amir G, Mogle P et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 1985; 106: 277-281.
29. Giacoia GP, Azubuike K, Taylor JR. Indomethacin and recurrent ileal perforations in a preterm infant. J Perinatol 1993; 13: 297-299.
30. Buchheit JQ, Stewart DL. Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates. Pediatrics 1994; 93: 32-36.
31. Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD. Patent ductus arteriosus in micropreemies and full-term infants: The relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 2003; 38: 492-496.
32. Knowles RG, Salter M, Brooks S, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 43-47.